Literature DB >> 12424647

Behavioral characterization of mild cognitive impairment.

Alexander Collie1, Paul Maruff, Jon Currie.   

Abstract

Results from recent investigations of behavioral and genetic outcomes in older people with mild cognitive impairment (MCI) have been inconsistent. These conflicting results may be attributed to between-study differences in the diagnostic systems employed, as well as the use of unreliable neuropsychological measures. We investigated behavioral and genetic outcomes in older people classified as having MCI according to novel criterion that required evidence of cognitive impairment on three consecutive neurological/neuropsychological assessments. One hundred and seventy four healthy older people were evaluated semi-annually for 12 months. Of these, 23 subjects were rated as having MCI on three consecutive assessments and were compared to 23 matched control subjects. Subjects rated as impaired on one or two of the three semi-annual assessments were also identified. MCI and matched control groups were compared on a range of behavioral measures. The prevalence of the Apolipoprotein E4 (ApoE4) allele was determined in all groups, and estimates of anxiety and depressive symptomatology were obtained. Subjective cognitive complaints were also assessed. Many subjects were classified as impaired on one or two assessments, however relatively few (n = 23) recorded consistent cognitive deficits. The most severe impairment observed in MCI subjects was on a test of pattern-location associative learning, however MCI subjects did not have insight into this impairment. The prevalence of the ApoE4 allele was not different between matched control and MCI groups. These results indicate that individuals with MCI can be differentiated from healthy older people and older people with transient cognitive impairments, but that such differentiation requires serial assessment of cognitive function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424647     DOI: 10.1076/jcen.24.6.720.8397

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  15 in total

1.  Reliability of repeated cognitive assessment of dementia using a brief computerized battery.

Authors:  Dustin Hammers; Elizabeth Spurgeon; Kelly Ryan; Carol Persad; Judith Heidebrink; Nancy Barbas; Roger Albin; Kirk Frey; David Darby; Bruno Giordani
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-06-01       Impact factor: 2.035

Review 2.  Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease.

Authors:  F Portet; P J Ousset; P J Visser; G B Frisoni; F Nobili; Ph Scheltens; B Vellas; J Touchon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

3.  Associations between variability of risk factors and health outcomes in longitudinal studies.

Authors:  Michael R Elliott; Mary D Sammel; Jessica Faul
Journal:  Stat Med       Date:  2012-07-20       Impact factor: 2.373

4.  Cognitive deficits and changes in neurometabolites after a lacunar infarct.

Authors:  M J E van Zandvoort; J van der Grond; L J Kappelle; E H F de Haan
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

5.  Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment.

Authors:  Lucas S Broster; Juan Li; Charles D Smith; Gregory A Jicha; Frederick A Schmitt; Yang Jiang
Journal:  J Clin Exp Neuropsychol       Date:  2013-09-30       Impact factor: 2.475

6.  Neuropsychological characteristics of mild cognitive impairment subgroups.

Authors:  O L Lopez; J T Becker; W J Jagust; A Fitzpatrick; M C Carlson; S T DeKosky; J Breitner; C G Lyketsos; B Jones; C Kawas; L H Kuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

7.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

8.  The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.

Authors:  C J Brainerd; V F Reyna; R C Petersen; G E Smith; A E Kenney; C J Gross; E S Taub; B L Plassman; G G Fisher
Journal:  Neuropsychology       Date:  2013-01       Impact factor: 3.295

9.  The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.

Authors:  Jerry J Buccafusco; Alvin V Terry; Scott J Webster; Daniel Martin; Elizabeth J Hohnadel; Kristy A Bouchard; Samantha E Warner
Journal:  Psychopharmacology (Berl)       Date:  2007-07-27       Impact factor: 4.530

10.  Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period.

Authors:  David A Loewenstein; Amarilis Acevedo; Brent J Small; Joscelyn Agron; Elizabeth Crocco; Ranjan Duara
Journal:  Dement Geriatr Cogn Disord       Date:  2009-04-09       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.